|
SLC30A7 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.08619996225445E-09 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.93601999999293E-05 |
| Normal-vs-Stage2 |
1.324200E-02 |
| Normal-vs-Stage3 |
5.370600E-04 |
| Normal-vs-Stage4 |
7.530500E-02 |
| Stage1-vs-Stage2 |
3.729000E-01 |
| Stage1-vs-Stage3 |
3.116000E-01 |
| Stage1-vs-Stage4 |
5.790000E-01 |
| Stage2-vs-Stage3 |
9.745800E-01 |
| Stage2-vs-Stage4 |
9.274600E-01 |
| Stage3-vs-Stage4 |
9.318400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.53219999915666E-08 |
| Normal-vs-AfricanAmerican |
2.804900E-04 |
| Normal-vs-Asian |
2.855200E-01 |
| Caucasian-vs-AfricanAmerican |
9.225800E-01 |
| Caucasian-vs-Asian |
7.607800E-01 |
| AfricanAmerican-vs-Asian |
7.563800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.91940000010749E-07 |
| Normal-vs-Female |
9.82000000204764E-08 |
| Male-vs-Female |
2.664100E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.655500E-03 |
| Normal-vs-Extreme_Weight |
3.440400E-04 |
| Normal-vs-Obese |
6.28369999999823E-05 |
| Normal-vs-Extreme_Obese |
2.135600E-01 |
| Normal_Weight-vs-Extreme_Weight |
6.710000E-01 |
| Normal_Weight-vs-Obese |
3.883200E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.044200E-01 |
| Extreme_Weight-vs-Obese |
1.475610E-01 |
| Extreme_Weight-vs-Extreme_Obese |
8.516400E-01 |
| Obese-vs-Extreme_Obese |
4.169800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.041800E-03 |
| Normal-vs-Age(41-60Yrs) |
6.180600475858E-10 |
| Normal-vs-Age(61-80Yrs) |
1.222350E-04 |
| Normal-vs-Age(81-100Yrs) |
1.210590E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.450800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.215200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.535770E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.354200E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.251760E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.954400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.68499999508853E-08 |
| Normal-VS-Type2 PRCC |
1.815360E-03 |
| Normal-VS-KIRP CIMP |
2.138400E-02 |
| Normal-VS-Unclassified PRCC |
1.189420E-04 |
| Type1 PRCC-VS-Type2 PRCC |
4.418400E-01 |
| Type1 PRCC-VS-KIRP CIMP |
5.294400E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
2.314200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
4.146400E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.552650E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
9.460800E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.937190E-03 |
| Normal-vs-N1 |
1.840260E-03 |
| Normal-vs-N2 |
2.160800E-01 |
| N0-vs-N1 |
1.225380E-01 |
| N0-vs-N2 |
2.189000E-01 |
| N1-vs-N2 |
7.355800E-01 |
|
|
